# LiveRamp Holdings, Inc.

Type: Company (RAMP)

Source: GetYourBrief — https://getyourbrief.com/entity/liveramp-holdings-inc
Canonical HTML page: https://getyourbrief.com/entity/liveramp-holdings-inc

## Recent coverage (3 stories, network-wide)

### Invenomic Capital Management Aggressively Expands Stake in LiveRamp Holdings
2026-03-17 01:33:18 · Sector: finance · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Invenomic Capital Management LP has increased its position in LiveRamp Holdings by 61.4%, signaling strong institutional confidence in the data connectivity platform. The move, disclosed in a recent SEC filing, brings Invenomic's total stake to nearly 470,000 shares.
Full story: https://getfinancebrief.com/story/invenomic-capital-management-liveramp-holdings-stake-increase

### Invenomic Capital Boosts LiveRamp Stake by 61% Amid Data Privacy Shift
2026-03-17 01:32:45 · Sector: saas · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Invenomic Capital Management LP has significantly expanded its position in LiveRamp Holdings, Inc. (NYSE: RAMP), increasing its stake by 61.4% to 469,766 shares. This institutional move underscores growing confidence in LiveRamp’s identity resolution platform as the advertising industry pivots toward privacy-first data collaboration.
Full story: https://getsaasbrief.com/story/invenomic-capital-increases-liveramp-stake-ramp

### Invenomic Capital Management Boosts LiveRamp Stake by 61% Amid AdTech Shift
2026-03-17 01:32:41 · Sector: marketing · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Invenomic Capital Management LP significantly increased its position in LiveRamp Holdings, Inc. (NYSE: RAMP), acquiring an additional 178,799 shares during the third quarter. This 61.4% boost brings the fund's total holdings to 469,766 shares, signaling strong institutional confidence in the identity resolution leader's market position.
Full story: https://getmarketingbrief.com/story/invenomic-capital-liveramp-stake-increase-adtech

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getyourbrief.com/guides/methodology for the full editorial methodology.